Randomized Controlled Trial Evaluating Levetiracetam as First-line Therapy for Seizures in Neonates: Evidence-based Medicine Viewpoint
- PMID: 32999112
Randomized Controlled Trial Evaluating Levetiracetam as First-line Therapy for Seizures in Neonates: Evidence-based Medicine Viewpoint
Comment on
-
Sharpe C, Reiner GE, Davis SL, et al; FOR THE NEOLEV2 INVESTIGATORS. Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial. Pediatrics. 2020;145(6):e20193182.Pediatrics. 2021 Jan;147(1):e2020036806. doi: 10.1542/peds.2020-036806. Pediatrics. 2021. PMID: 33384298 Free PMC article. No abstract available.
Publication types
LinkOut - more resources
Full Text Sources